NasdaqCM - Nasdaq Real Time Price USD
Forte Biosciences, Inc. (FBRX)
6.72
-0.16
(-2.33%)
As of 11:55:54 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHEN HUBERT C President | Conversion of Exercise of derivative security | Dec 29, 2023 | 93,405 |
| GRYSKA DAVID W Director | Stock Award(Grant) | Jul 31, 2023 | 148,514 |
| KORNFELD STEVEN Director | Stock Award(Grant) | Jul 31, 2023 | 99,009 |
| RILEY ANTONY A Chief Financial Officer | Conversion of Exercise of derivative security | Apr 1, 2025 | 31,218 |
| WAGNER PAUL A Chief Executive Officer | Conversion of Exercise of derivative security | Apr 1, 2025 | 79,788 |
| WILLIAMS DONALD ALLEN Director | Stock Award(Grant) | Jul 31, 2023 | 59,405 |
Related Tickers
PVLA Palvella Therapeutics, Inc.
27.76
+3.14%
NGNE Neurogene Inc.
14.72
+6.44%
ABVC ABVC BioPharma, Inc.
0.8439
+1.48%
MBIO Mustang Bio, Inc.
1.3450
+5.08%
PCSA Processa Pharmaceuticals, Inc.
0.2372
+8.06%
DNTH Dianthus Therapeutics, Inc.
21.23
-2.93%
SXTP 60 Degrees Pharmaceuticals, Inc.
2.8200
+5.62%
TRML Tourmaline Bio, Inc.
17.71
+2.22%
CMRX Chimerix, Inc.
8.54
0.00%
ATXS Astria Therapeutics, Inc.
4.8800
+5.63%